Abbonarsi

POST-THORACOTOMY ANALGESIA - 03/09/11

Doi : 10.1016/S0889-8537(05)70250-9 
Ian D. Conacher, MD, MB *

Riassunto

Analgesia for patients with pain of thoracic surgical origin is examined from an organizational perspective. Conventional approaches are discussed in the light of the dynamics that are driving managed healthcare resources in global economies. Not all patients can expect to receive gold standard techniques within five-star environments, but each individual is entitled to receive a similar measure of quality pain relief. This aim should be the prime one of those charged with providing pain relief services.

A state-of-the-art review from 2 decades ago could be made by describing the application of local anesthetics to the intercostal space at the time of surgery and, more exotically, into the epidural space with percutaneously sited catheters after surgery.14 The bulk of patients had as-required prescriptions of opiates, probably by intramuscular injection; few received nonsteroidal anti-inflammatory drugs (NSAIDs) by mouth or rectally. There was interest in the use of a cryoprobe for intercostal nerve blockade, but recognition that it caused post-thoracotomy neuralgia led to the demise as a pain-relief technique.5, 13, 42 Restoration of function, in terms of pulmonary function tests, was the only realistic outcome measure. Bromage6 proposed the measure, respiration restoration factor, an index that reflected the recent knowledge that reduction in pain levels counteracted the restrictive effects of surgery on chest wall mechanics and led to a reduction in what was regarded as an obligatory effect of thoracotomy, by way of which almost all surgery was conducted.6

Since then, there has been an analgesic revolution, notably in the use of neuraxial opioids. With technologic advances, such as sophisticated delivery systems that can be patient-operated, there has been an explosion of alternatives for relieving the suffering of thoracic trauma and surgically induced pain.14, 17, 20, 21, 36, 39, 53 As an outcome measure, improved function waned with the rise of pain analog scoring systems, a concept of opioid sparing, and with detecting and preempting changes in surrogate markers of pain found in the biochemistry of stress.

North America has been slower than Europe to recognize that the legacy of tobacco on an elderly population demographic is the creation of an epidemic of cigarette smoking–related pulmonary disease that rivals cardiovascular disease. By 2020, obstructive airways disease will be the fourth largest killing condition. Lung cancer is now the third commonest cancer in Western democracies. In many cases, surgery is the only option with a chance of cure, and requires considerable investment from the economy. Practice increasingly is viewed from a consumerist, rather than medical, perspective because of the politicization of the funding of managed healthcare systems. Pain-relief services are not immune from scrutiny from various directions.65 Statutory regulations and bodies, now being commissioned in many democracies, will probe for evidence-base, quality, and financial efficiency.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to Ian D. Conacher, MD, MB, Department of Thoracic Anaesthesia, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust, Freeman Road, Newcastle upon Tyne, NE7 7DN, United Kingdom


© 2001  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 19 - N° 3

P. 611-625 - settembre 2001 Ritorno al numero
Articolo precedente Articolo precedente
  • ANESTHESIA CONSIDERATIONS FOR LUNG VOLUME REDUCTION SURGERY
  • Edda M. Tschernko

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.